Verano Holdings Past Earnings Performance

Past criteria checks 0/6

Verano Holdings's earnings have been declining at an average annual rate of -58.7%, while the Pharmaceuticals industry saw earnings growing at 31.5% annually. Revenues have been growing at an average rate of 38% per year.

Key information

-58.7%

Earnings growth rate

-94.4%

EPS growth rate

Pharmaceuticals Industry Growth	23.1%
Revenue growth rate	38.0%
Return on equity	-9.5%
Net Margin	-12.5%
Next Earnings Update	08 May 2024

Recent past performance updates

Recent updates

Are Investors Undervaluing Verano Holdings Corp. (CSE:VRNO) By 31%?

Oct 07

Why Investors Shouldn't Be Surprised By Verano Holdings Corp.'s (CSE:VRNO) 34% Share Price Surge

Sep 02

An Intrinsic Calculation For Verano Holdings Corp. (CSE:VRNO) Suggests It's 27% Undervalued

Jan 26

Verano Holdings Corp. (CSE:VRNO) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 12

Verano Holdings' (CSE:VRNO) Earnings Are Weaker Than They Seem

May 25

Revenue & Expenses Breakdown
Beta

How Verano Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NEOE:VRNO Revenue, expenses and earnings (USD Millions)
Date	Revenue	Earnings	G+A Expenses
31 Dec 23	938	-117	316
30 Sep 23	927	-256	327
30 Jun 23	915	-281	327
31 Mar 23	904	-278	342
31 Dec 22	879	-269	344
30 Sep 22	865	-60	357
30 Jun 22	844	-30	348
31 Mar 22	819	-50	318
31 Dec 21	738	-58	271
30 Sep 21	600	-135	206
30 Jun 21	458	-35	141
31 Mar 21	307	10	77
31 Dec 20	229	38	43
30 Sep 20	179	127	33
31 Dec 19	66	-18	37
31 Dec 18	31	-1	10

Quality Earnings: VRNO is currently unprofitable.

Growing Profit Margin: VRNO is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: VRNO is unprofitable, and losses have increased over the past 5 years at a rate of 58.7% per year.

Accelerating Growth: Unable to compare VRNO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: VRNO is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (22%).

Return on Equity

High ROE: VRNO has a negative Return on Equity (-9.46%), as it is currently unprofitable.

Verano Holdings Past Earnings Performance

Past criteria checks 0/6

Key information

Recent past performance updates

Verano Holdings Corp. to Report Q1, 2024 Results on May 08, 2024

Verano Holdings Corp. to Report Q4, 2023 Results on Feb 29, 2024

Third quarter 2023 earnings: EPS misses analyst expectations

Verano Holdings Corp. to Report Q3, 2023 Results on Nov 08, 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Verano Holdings Corp. to Report Q2, 2023 Results on Aug 08, 2023

Recent updates

Verano Holdings Corp. to Report Q1, 2024 Results on May 08, 2024

Verano Holdings Corp., Annual General Meeting, Jun 20, 2024

Verano Holdings Corp. announced delayed annual 10-K filing

Verano Holdings Corp. to Report Q4, 2023 Results on Feb 29, 2024

Verano Holdings Corp. Reimagines (the) Essence Brand and Introduces (the) Essence Nectar Line in Core Markets, Combining Bespoke Graphic Art and Terpene-Rich Full-Spectrum Cannabis Products

Consensus EPS estimates fall by 32%

Third quarter 2023 earnings: EPS misses analyst expectations

New minor risk - Share price stability

Verano Holdings Corp. Announces the Launch of Savvy Threads

Are Investors Undervaluing Verano Holdings Corp. (CSE:VRNO) By 31%?

Verano Holdings Corp. to Report Q3, 2023 Results on Nov 08, 2023

Now 21% undervalued

Why Investors Shouldn't Be Surprised By Verano Holdings Corp.'s (CSE:VRNO) 34% Share Price Surge

Consensus EPS estimates fall by 115%

New minor risk - Profitability

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

High number of new and inexperienced directors

Verano Holdings Corp. Announces Executive Changes

New minor risk - Shareholder dilution

Verano Holdings Corp. to Report Q2, 2023 Results on Aug 08, 2023

Verano Holdings Corp Introduces On The Rocks, New Multi-Format Brand Anchored Around Solventless Extraction Methods, Across Core Markets

Verano Holdings Corp. Announces Executive Changes

First quarter 2023 earnings: EPS exceeds analyst expectations

Full year 2022 earnings released

Founder exercised options to buy CA$76k worth of stock.

Director recently sold CA$192k worth of stock

Director recently sold CA$81k worth of stock

Verano Holdings Corp. Announces Departure of Ed Brown from Its Board

Now 20% undervalued after recent price drop

An Intrinsic Calculation For Verano Holdings Corp. (CSE:VRNO) Suggests It's 27% Undervalued

Now 22% undervalued after recent price drop

Now 21% undervalued after recent price drop

Now 28% undervalued after recent price drop

Chief Financial Officer recently sold CA$55k worth of stock

Consensus forecasts updated

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

High number of new and inexperienced directors

Verano Holdings Corp. Launches BITS, Company's New Low-Dose, High-Function Edibles

Verano Holdings Corp. to Report Q3, 2022 Results on Nov 14, 2022

Goodness Growth Holdings, Inc. Commences Action in the Supreme Court of British Columbia Against Verano Holdings Corp

Verano Holdings Corp. (CNSX : VRNO) completed the acquisition of WSCC, Inc.

Verano Holdings Corp. Appoints Lawrence Hirsh as New Member of the Board of Directors and Chair of the Audit Committee

Verano Holdings Corp. announced delayed 10-Q filing

Verano Holdings Corp. Introduces New Flower and Extract Brand, Savvy, in Seven Core Cannabis Markets

Verano Holdings Corp. to Report Q2, 2022 Results on Aug 16, 2022

High number of new and inexperienced directors

Verano Holdings Corp., Annual General Meeting, Aug 03, 2022

Verano Holdings Corp. Announces the Reopening of Zen Leaf Canton in Its New Location At 3224 Cleveland Ave NW on April 4, 2022 At 10 A.M. Local Time

Verano Holdings Corp. to Report Q4, 2021 Results on Apr 07, 2022

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Verano Holdings Corp. (CNSX:VRNO) entered into a definitive arrangement to acquire Goodness Growth Holdings, Inc. (CNSX:GDNS) for approximately $300 million.

Verano Holdings Corp. (CNSX:VRNO) completed the acquisition of 100% equity interests in Connecticut Pharmaceutical Solutions, LLC from Tuatara Capital, L.P. and others.

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released

Investor sentiment improved over the past week

Chairman & CEO recently bought CA$1.3m worth of stock

General Counsel & Chief Legal Officer exercised options and sold CA$1.0m worth of stock

Verano Holdings Corp. (CNSX:VRNO) acquired One medical cannabis growing operation, One processing operation and Two dispensaries in Maryland.

Investor sentiment deteriorated over the past week

Consensus forecasts updated

Verano Holdings Corp. (CSE:VRNO) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Second quarter 2021 earnings released: EPS US$0.053 (vs US$5.06 in 2Q 2020)

Verano Holdings Corp. (CNSX:VRNO) completed the cquisition of Agri-Kind, LLC and Agronomed Holdings Inc.

Verano Holdings Corp. (CNSX:VRNO) acquired NSE Pennsylvania LLC.

Consensus EPS estimates increase to US$0.99

Verano Holdings Corp. (CNSX:VRNO) completed the acquisition of Terravida Holistic Centers, LLC and GVB Holding Group, LLC.

Verano Holdings' (CSE:VRNO) Earnings Are Weaker Than They Seem

Revenue & Expenses Breakdown
Beta